Pharmaceuticals

Europe Hemophilia Treatment Drugs Market Report 2017

  • QYR904896
  • 127 Pages
  • February 2017
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Hemophilia Treatment Drugs

Revenue, means the sales value of Hemophilia Treatment Drugs

This report studies sales (consumption) of Hemophilia Treatment Drugs in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

Pfizer

Biotest

CSL Behring

Kedrion

Octapharma

Shire

Novo Nordisk

Bayer

F. Hoffmann-La Roche

Biogen

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Hemophilia Treatment Drugs in these countries, from 2011 to 2021 (forecast), like

Germany

France

UK

Russia

Italy

Spain

Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

Recombinant Coagulation Factor Concentrates

Plasma Derived Coagulation Factor Concentrates

Desmopressin

Antifibrinolytic Agents

Split by application, this report focuses on sales, market share and growth rate of Hemophilia Treatment Drugs in each application, can be divided into

Hemophilia A

Hemophilia B

Others

Table of Contents

Europe Hemophilia Treatment Drugs Market Report 2017

1 Hemophilia Treatment Drugs Overview

1.1 Product Overview and Scope of Hemophilia Treatment Drugs

1.2 Classification of Hemophilia Treatment Drugs

1.2.1 Recombinant Coagulation Factor Concentrates

1.2.2 Plasma Derived Coagulation Factor Concentrates

1.2.3 Desmopressin

1.2.4 Antifibrinolytic Agents

1.3 Application of Hemophilia Treatment Drugs

1.3.1 Hemophilia A

1.3.2 Hemophilia B

1.3.3 Others

1.4 Hemophilia Treatment Drugs Market by Countries

1.4.1 Germany Status and Prospect (2012-2022)

1.4.2 France Status and Prospect (2012-2022)

1.4.3 UK Status and Prospect (2012-2022)

1.4.4 Russia Status and Prospect (2012-2022)

1.4.5 Italy Status and Prospect (2012-2022)

1.4.6 Spain Status and Prospect (2012-2022)

1.4.7 Benelux Status and Prospect (2012-2022)

1.5 Europe Market Size (Value and Volume) of Hemophilia Treatment Drugs (2012-2022)

1.5.1 Europe Hemophilia Treatment Drugs Sales and Growth Rate (2012-2022)

1.5.2 Europe Hemophilia Treatment Drugs Revenue and Growth Rate (2012-2022)

2 Europe Hemophilia Treatment Drugs by Manufacturers, Type and Application

2.1 Europe Hemophilia Treatment Drugs Market Competition by Manufacturers

2.1.1 Europe Hemophilia Treatment Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)

2.1.2 Europe Hemophilia Treatment Drugs Revenue and Share by Manufacturers (2015 and 2016)

2.2 Europe Hemophilia Treatment Drugs (Volume and Value) by Type

2.2.1 Europe Hemophilia Treatment Drugs Sales and Market Share by Type (2012-2017)

2.2.2 Europe Hemophilia Treatment Drugs Revenue and Market Share by Type (2012-2017)

2.3 Europe Hemophilia Treatment Drugs (Volume and Value) by Countries

2.3.1 Europe Hemophilia Treatment Drugs Sales and Market Share by Countries (2012-2017)

2.3.2 Europe Hemophilia Treatment Drugs Revenue and Market Share by Countries (2012-2017)

2.4 Europe Hemophilia Treatment Drugs (Volume) by Application

3 Germany Hemophilia Treatment Drugs (Volume, Value and Sales Price)

3.1 Germany Hemophilia Treatment Drugs Sales and Value (2012-2017)

3.1.1 Germany Hemophilia Treatment Drugs Sales and Growth Rate (2012-2017)

3.1.2 Germany Hemophilia Treatment Drugs Revenue and Growth Rate (2012-2017)

3.1.3 Germany Hemophilia Treatment Drugs Sales Price Trend (2012-2017)

3.2 Germany Hemophilia Treatment Drugs Sales and Market Share by Manufacturers

3.3 Germany Hemophilia Treatment Drugs Sales and Market Share by Type

3.4 Germany Hemophilia Treatment Drugs Sales and Market Share by Application

4 France Hemophilia Treatment Drugs (Volume, Value and Sales Price)

4.1 France Hemophilia Treatment Drugs Sales and Value (2012-2017)

4.1.1 France Hemophilia Treatment Drugs Sales and Growth Rate (2012-2017)

4.1.2 France Hemophilia Treatment Drugs Revenue and Growth Rate (2012-2017)

4.1.4 France Hemophilia Treatment Drugs Sales Price Trend (2012-2017)

4.2 France Hemophilia Treatment Drugs Sales and Market Share by Manufacturers

4.3 France Hemophilia Treatment Drugs Sales and Market Share by Type

4.4 France Hemophilia Treatment Drugs Sales and Market Share by Application

5 UK Hemophilia Treatment Drugs (Volume, Value and Sales Price)

5.1 UK Hemophilia Treatment Drugs Sales and Value (2012-2017)

5.1.1 UK Hemophilia Treatment Drugs Sales and Growth Rate (2012-2017)

5.1.2 UK Hemophilia Treatment Drugs Revenue and Growth Rate (2012-2017)

5.1.5 UK Hemophilia Treatment Drugs Sales Price Trend (2012-2017)

5.2 UK Hemophilia Treatment Drugs Sales and Market Share by Manufacturers

5.3 UK Hemophilia Treatment Drugs Sales and Market Share by Type

5.4 UK Hemophilia Treatment Drugs Sales and Market Share by Application

6 Russia Hemophilia Treatment Drugs (Volume, Value and Sales Price)

6.1 Russia Hemophilia Treatment Drugs Sales and Value (2012-2017)

6.1.1 Russia Hemophilia Treatment Drugs Sales and Growth Rate (2012-2017)

6.1.2 Russia Hemophilia Treatment Drugs Revenue and Growth Rate (2012-2017)

6.1.6 Russia Hemophilia Treatment Drugs Sales Price Trend (2012-2017)

6.2 Russia Hemophilia Treatment Drugs Sales and Market Share by Manufacturers

6.3 Russia Hemophilia Treatment Drugs Sales and Market Share by Type

6.4 Russia Hemophilia Treatment Drugs Sales and Market Share by Application

7 Italy Hemophilia Treatment Drugs (Volume, Value and Sales Price)

7.1 Italy Hemophilia Treatment Drugs Sales and Value (2012-2017)

7.1.1 Italy Hemophilia Treatment Drugs Sales and Growth Rate (2012-2017)

7.1.2 Italy Hemophilia Treatment Drugs Revenue and Growth Rate (2012-2017)

7.1.7 Italy Hemophilia Treatment Drugs Sales Price Trend (2012-2017)

7.2 Italy Hemophilia Treatment Drugs Sales and Market Share by Manufacturers

7.3 Italy Hemophilia Treatment Drugs Sales and Market Share by Type

7.4 Italy Hemophilia Treatment Drugs Sales and Market Share by Application

8 Spain Hemophilia Treatment Drugs (Volume, Value and Sales Price)

8.1 Spain Hemophilia Treatment Drugs Sales and Value (2012-2017)

8.1.1 Spain Hemophilia Treatment Drugs Sales and Growth Rate (2012-2017)

8.1.2 Spain Hemophilia Treatment Drugs Revenue and Growth Rate (2012-2017)

8.1.8 Spain Hemophilia Treatment Drugs Sales Price Trend (2012-2017)

8.2 Spain Hemophilia Treatment Drugs Sales and Market Share by Manufacturers

8.3 Spain Hemophilia Treatment Drugs Sales and Market Share by Type

8.4 Spain Hemophilia Treatment Drugs Sales and Market Share by Application

9 Benelux Hemophilia Treatment Drugs (Volume, Value and Sales Price)

9.1 Benelux Hemophilia Treatment Drugs Sales and Value (2012-2017)

9.1.1 Benelux Hemophilia Treatment Drugs Sales and Growth Rate (2012-2017)

9.1.2 Benelux Hemophilia Treatment Drugs Revenue and Growth Rate (2012-2017)

9.1.9 Benelux Hemophilia Treatment Drugs Sales Price Trend (2012-2017)

9.2 Benelux Hemophilia Treatment Drugs Sales and Market Share by Manufacturers

9.3 Benelux Hemophilia Treatment Drugs Sales and Market Share by Type

9.4 Benelux Hemophilia Treatment Drugs Sales and Market Share by Application

10 Europe Hemophilia Treatment Drugs Manufacturers Analysis

10.1 Pfizer

10.1.1 Company Basic Information, Manufacturing Base and Competitors

10.1.2 Hemophilia Treatment Drugs Product Type, Application and Specification

10.1.2.1 Recombinant Coagulation Factor Concentrates

10.1.2.2 Plasma Derived Coagulation Factor Concentrates

10.1.3 Pfizer Hemophilia Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

10.1.4 Main Business/Business Overview

10.2 Biotest

10.2.1 Company Basic Information, Manufacturing Base and Competitors

10.2.2 Hemophilia Treatment Drugs Product Type, Application and Specification

10.2.2.1 Recombinant Coagulation Factor Concentrates

10.2.2.2 Plasma Derived Coagulation Factor Concentrates

10.2.3 Biotest Hemophilia Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

10.2.4 Main Business/Business Overview

10.3 CSL Behring

10.3.1 Company Basic Information, Manufacturing Base and Competitors

10.3.2 Hemophilia Treatment Drugs Product Type, Application and Specification

10.3.2.1 Recombinant Coagulation Factor Concentrates

10.3.2.2 Plasma Derived Coagulation Factor Concentrates

10.3.3 CSL Behring Hemophilia Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

10.3.4 Main Business/Business Overview

10.4 Kedrion

10.4.1 Company Basic Information, Manufacturing Base and Competitors

10.4.2 Hemophilia Treatment Drugs Product Type, Application and Specification

10.4.2.1 Recombinant Coagulation Factor Concentrates

10.4.2.2 Plasma Derived Coagulation Factor Concentrates

10.4.3 Kedrion Hemophilia Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

10.4.4 Main Business/Business Overview

10.5 Octapharma

10.5.1 Company Basic Information, Manufacturing Base and Competitors

10.5.2 Hemophilia Treatment Drugs Product Type, Application and Specification

10.5.2.1 Recombinant Coagulation Factor Concentrates

10.5.2.2 Plasma Derived Coagulation Factor Concentrates

10.5.3 Octapharma Hemophilia Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

10.5.4 Main Business/Business Overview

10.6 Shire

10.6.1 Company Basic Information, Manufacturing Base and Competitors

10.6.2 Hemophilia Treatment Drugs Product Type, Application and Specification

10.6.2.1 Recombinant Coagulation Factor Concentrates

10.6.2.2 Plasma Derived Coagulation Factor Concentrates

10.6.3 Shire Hemophilia Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

10.6.4 Main Business/Business Overview

10.7 Novo Nordisk

10.7.1 Company Basic Information, Manufacturing Base and Competitors

10.7.2 Hemophilia Treatment Drugs Product Type, Application and Specification

10.7.2.1 Recombinant Coagulation Factor Concentrates

10.7.2.2 Plasma Derived Coagulation Factor Concentrates

10.7.3 Novo Nordisk Hemophilia Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

10.7.4 Main Business/Business Overview

10.8 Bayer

10.8.1 Company Basic Information, Manufacturing Base and Competitors

10.8.2 Hemophilia Treatment Drugs Product Type, Application and Specification

10.8.2.1 Recombinant Coagulation Factor Concentrates

10.8.2.2 Plasma Derived Coagulation Factor Concentrates

10.8.3 Bayer Hemophilia Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

10.8.4 Main Business/Business Overview

10.9 F. Hoffmann-La Roche

10.9.1 Company Basic Information, Manufacturing Base and Competitors

10.9.2 Hemophilia Treatment Drugs Product Type, Application and Specification

10.9.2.1 Recombinant Coagulation Factor Concentrates

10.9.2.2 Plasma Derived Coagulation Factor Concentrates

10.9.3 F. Hoffmann-La Roche Hemophilia Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

10.9.4 Main Business/Business Overview

10.10 Biogen

10.10.1 Company Basic Information, Manufacturing Base and Competitors

10.10.2 Hemophilia Treatment Drugs Product Type, Application and Specification

10.10.2.1 Recombinant Coagulation Factor Concentrates

10.10.2.2 Plasma Derived Coagulation Factor Concentrates

10.10.3 Biogen Hemophilia Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

10.10.4 Main Business/Business Overview

11 Hemophilia Treatment Drugs Manufacturing Cost Analysis

11.1 Hemophilia Treatment Drugs Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.1.2 Price Trend of Key Raw Materials

11.1.3 Key Suppliers of Raw Materials

11.1.4 Market Concentration Rate of Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Manufacturing Process Analysis of Hemophilia Treatment Drugs

12 Industrial Chain, Sourcing Strategy and Downstream Buyers

12.1 Hemophilia Treatment Drugs Industrial Chain Analysis

12.2 Upstream Raw Materials Sourcing

12.3 Raw Materials Sources of Hemophilia Treatment Drugs Major Manufacturers in 2015

12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders

13.1 Marketing Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Development Trend

13.2 Market Positioning

13.2.1 Pricing Strategy

13.2.2 Brand Strategy

13.2.3 Target Client

13.3 Distributors/Traders List

14 Europe Hemophilia Treatment Drugs Market Forecast (2017-2022)

14.1 Germany Hemophilia Treatment Drugs Sales Forecast (2017-2022)

14.2 France Hemophilia Treatment Drugs Sales Forecast (2017-2022)

14.3 UK Hemophilia Treatment Drugs Sales Forecast (2017-2022)

14.4 Russia Hemophilia Treatment Drugs Sales Forecast (2017-2022)

14.5 Italy Hemophilia Treatment Drugs Sales Forecast (2017-2022)

14.6 Spain Hemophilia Treatment Drugs Sales Forecast (2017-2022)

14.7 Benelux Hemophilia Treatment Drugs Sales Forecast (2017-2022)

14.8 Europe Hemophilia Treatment Drugs Sales Forecast by Type (2017-2022)

14.9 Europe Hemophilia Treatment Drugs Sales Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix

Methodology

Analyst Introduction

Data Source

List of Tables and Figures

Figure Picture of Hemophilia Treatment Drugs

Table Classification of Hemophilia Treatment Drugs

Figure Europe Sales Market Share of Hemophilia Treatment Drugs by Type in 2015

Figure Recombinant Coagulation Factor Concentrates Picture

Figure Plasma Derived Coagulation Factor Concentrates Picture

Figure Desmopressin Picture

Figure Antifibrinolytic Agents Picture

Table Application of Hemophilia Treatment Drugs

Figure Europe Sales Market Share of Hemophilia Treatment Drugs by Application in 2015

Figure Hemophilia A Examples

Figure Hemophilia B Examples

Figure Others Examples

Figure Germany Hemophilia Treatment Drugs Revenue and Growth Rate (2012-2022)

Figure France Hemophilia Treatment Drugs Revenue and Growth Rate (2012-2022)

Figure UK Hemophilia Treatment Drugs Revenue and Growth Rate (2012-2022)

Figure Russia Hemophilia Treatment Drugs Revenue and Growth Rate (2012-2022)

Figure Italy Hemophilia Treatment Drugs Revenue and Growth Rate (2012-2022)

Figure Spain Hemophilia Treatment Drugs Revenue and Growth Rate (2012-2022)

Figure Benelux Hemophilia Treatment Drugs Revenue and Growth Rate (2012-2022)

Figure Europe Hemophilia Treatment Drugs Sales and Growth Rate (2012-2022)

Figure Europe Hemophilia Treatment Drugs Revenue and Growth Rate (2012-2022)

Table Europe Hemophilia Treatment Drugs Sales of Key Manufacturers (2015 and 2016)

Table Europe Hemophilia Treatment Drugs Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Hemophilia Treatment Drugs Sales Share by Manufacturers

Figure 2016 Hemophilia Treatment Drugs Sales Share by Manufacturers

Table Europe Hemophilia Treatment Drugs Revenue by Manufacturers (2015 and 2016)

Table Europe Hemophilia Treatment Drugs Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Europe Hemophilia Treatment Drugs Revenue Share by Manufacturers

Table 2016 Europe Hemophilia Treatment Drugs Revenue Share by Manufacturers

Table Europe Hemophilia Treatment Drugs Sales and Market Share by Type (2012-2017)

Table Europe Hemophilia Treatment Drugs Sales Share by Type (2012-2017)

Figure Sales Market Share of Hemophilia Treatment Drugs by Type (2012-2017)

Figure Europe Hemophilia Treatment Drugs Sales Growth Rate by Type (2012-2017)

Table Europe Hemophilia Treatment Drugs Revenue and Market Share by Type (2012-2017)

Table Europe Hemophilia Treatment Drugs Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Hemophilia Treatment Drugs by Type (2012-2017)

Figure Europe Hemophilia Treatment Drugs Revenue Growth Rate by Type (2012-2017)

Table Europe Hemophilia Treatment Drugs Sales and Market Share by Countries (2012-2017)

Table Europe Hemophilia Treatment Drugs Sales Share by Countries (2012-2017)

Figure Sales Market Share of Hemophilia Treatment Drugs by Countries (2012-2017)

Table Europe Hemophilia Treatment Drugs Revenue and Market Share by Countries (2012-2017)

Table Europe Hemophilia Treatment Drugs Revenue Share by Countries (2012-2017)

Figure Revenue Market Share of Hemophilia Treatment Drugs by Countries (2012-2017)

Table Europe Hemophilia Treatment Drugs Sales and Market Share by Application (2012-2017)

Table Europe Hemophilia Treatment Drugs Sales Share by Application (2012-2017)

Figure Sales Market Share of Hemophilia Treatment Drugs by Application (2012-2017)

Figure Germany Hemophilia Treatment Drugs Sales and Growth Rate (2012-2017)

Figure Germany Hemophilia Treatment Drugs Revenue and Growth Rate (2012-2017)

Figure Germany Hemophilia Treatment Drugs Sales Price Trend (2012-2017)

Table Germany Hemophilia Treatment Drugs Sales by Manufacturers (2015 and 2016)

Table Germany Hemophilia Treatment Drugs Market Share by Manufacturers (2015 and 2016)

Table Germany Hemophilia Treatment Drugs Sales by Type (2015 and 2016)

Table Germany Hemophilia Treatment Drugs Market Share by Type (2015 and 2016)

Table Germany Hemophilia Treatment Drugs Sales by Application (2015 and 2016)

Table Germany Hemophilia Treatment Drugs Market Share by Application (2015 and 2016)

Figure France Hemophilia Treatment Drugs Sales and Growth Rate (2012-2017)

Figure France Hemophilia Treatment Drugs Revenue and Growth Rate (2012-2017)

Figure France Hemophilia Treatment Drugs Sales Price Trend (2012-2017)

Table France Hemophilia Treatment Drugs Sales by Manufacturers (2015 and 2016)

Table France Hemophilia Treatment Drugs Market Share by Manufacturers (2015 and 2016)

Table France Hemophilia Treatment Drugs Sales by Type (2015 and 2016)

Table France Hemophilia Treatment Drugs Market Share by Type (2015 and 2016)

Table France Hemophilia Treatment Drugs Sales by Application (2015 and 2016)

Table France Hemophilia Treatment Drugs Market Share by Application (2015 and 2016)

Figure UK Hemophilia Treatment Drugs Sales and Growth Rate (2012-2017)

Figure UK Hemophilia Treatment Drugs Revenue and Growth Rate (2012-2017)

Figure UK Hemophilia Treatment Drugs Sales Price Trend (2012-2017)

Table UK Hemophilia Treatment Drugs Sales by Manufacturers (2015 and 2016)

Table UK Hemophilia Treatment Drugs Market Share by Manufacturers (2015 and 2016)

Table UK Hemophilia Treatment Drugs Sales by Type (2015 and 2016)

Table UK Hemophilia Treatment Drugs Market Share by Type (2015 and 2016)

Table UK Hemophilia Treatment Drugs Sales by Application (2015 and 2016)

Table UK Hemophilia Treatment Drugs Market Share by Application (2015 and 2016)

Figure Russia Hemophilia Treatment Drugs Sales and Growth Rate (2012-2017)

Figure Russia Hemophilia Treatment Drugs Revenue and Growth Rate (2012-2017)

Figure Russia Hemophilia Treatment Drugs Sales Price Trend (2012-2017)

Table Russia Hemophilia Treatment Drugs Sales by Manufacturers (2015 and 2016)

Table Russia Hemophilia Treatment Drugs Market Share by Manufacturers (2015 and 2016)

Table Russia Hemophilia Treatment Drugs Sales by Type (2015 and 2016)

Table Russia Hemophilia Treatment Drugs Market Share by Type (2015 and 2016)

Table Russia Hemophilia Treatment Drugs Sales by Application (2015 and 2016)

Table Russia Hemophilia Treatment Drugs Market Share by Application (2015 and 2016)

Figure Italy Hemophilia Treatment Drugs Sales and Growth Rate (2012-2017)

Figure Italy Hemophilia Treatment Drugs Revenue and Growth Rate (2012-2017)

Figure Italy Hemophilia Treatment Drugs Sales Price Trend (2012-2017)

Table Italy Hemophilia Treatment Drugs Sales by Manufacturers (2015 and 2016)

Table Italy Hemophilia Treatment Drugs Market Share by Manufacturers (2015 and 2016)

Table Italy Hemophilia Treatment Drugs Sales by Type (2015 and 2016)

Table Italy Hemophilia Treatment Drugs Market Share by Type (2015 and 2016)

Table Italy Hemophilia Treatment Drugs Sales by Application (2015 and 2016)

Table Italy Hemophilia Treatment Drugs Market Share by Application (2015 and 2016)

Figure Spain Hemophilia Treatment Drugs Sales and Growth Rate (2012-2017)

Figure Spain Hemophilia Treatment Drugs Revenue and Growth Rate (2012-2017)

Figure Spain Hemophilia Treatment Drugs Sales Price Trend (2012-2017)

Table Spain Hemophilia Treatment Drugs Sales by Manufacturers (2015 and 2016)

Table Spain Hemophilia Treatment Drugs Market Share by Manufacturers (2015 and 2016)

Table Spain Hemophilia Treatment Drugs Sales by Type (2015 and 2016)

Table Spain Hemophilia Treatment Drugs Market Share by Type (2015 and 2016)

Table Spain Hemophilia Treatment Drugs Sales by Application (2015 and 2016)

Table Spain Hemophilia Treatment Drugs Market Share by Application (2015 and 2016)

Figure Benelux Hemophilia Treatment Drugs Sales and Growth Rate (2012-2017)

Figure Benelux Hemophilia Treatment Drugs Revenue and Growth Rate (2012-2017)

Figure Benelux Hemophilia Treatment Drugs Sales Price Trend (2012-2017)

Table Benelux Hemophilia Treatment Drugs Sales by Manufacturers (2015 and 2016)

Table Benelux Hemophilia Treatment Drugs Market Share by Manufacturers (2015 and 2016)

Table Benelux Hemophilia Treatment Drugs Sales by Type (2015 and 2016)

Table Benelux Hemophilia Treatment Drugs Market Share by Type (2015 and 2016)

Table Benelux Hemophilia Treatment Drugs Sales by Application (2015 and 2016)

Table Benelux Hemophilia Treatment Drugs Market Share by Application (2015 and 2016)

Table Hemophilia Treatment Drugs Basic Information List

Table Pfizer Hemophilia Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Pfizer Hemophilia Treatment Drugs Sales Market Share (2012-2017)

Table Biotest Basic Information List

Table Biotest Hemophilia Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Biotest Hemophilia Treatment Drugs Sales Market Share (2012-2017)

Table CSL Behring Basic Information List

Table CSL Behring Hemophilia Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table CSL Behring Hemophilia Treatment Drugs Sales Market Share (2012-2017)

Table Kedrion Basic Information List

Table Kedrion Hemophilia Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Kedrion Hemophilia Treatment Drugs Sales Market Share (2012-2017)

Table Octapharma Basic Information List

Table Octapharma Hemophilia Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Octapharma Hemophilia Treatment Drugs Sales Market Share (2012-2017)

Table Shire Basic Information List

Table Shire Hemophilia Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Shire Hemophilia Treatment Drugs Sales Market Share (2012-2017)

Table Novo Nordisk Basic Information List

Table Novo Nordisk Hemophilia Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Novo Nordisk Hemophilia Treatment Drugs Sales Market Share (2012-2017)

Table Bayer Basic Information List

Table Bayer Hemophilia Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Bayer Hemophilia Treatment Drugs Sales Market Share (2012-2017)

Table F. Hoffmann-La Roche Basic Information List

Table F. Hoffmann-La Roche Hemophilia Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table F. Hoffmann-La Roche Hemophilia Treatment Drugs Sales Market Share (2012-2017)

Table Biogen Basic Information List

Table Biogen Hemophilia Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Biogen Hemophilia Treatment Drugs Sales Market Share (2012-2017)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Hemophilia Treatment Drugs

Figure Manufacturing Process Analysis of Hemophilia Treatment Drugs

Figure Hemophilia Treatment Drugs Industrial Chain Analysis

Table Raw Materials Sources of Hemophilia Treatment Drugs Major Manufacturers in 2015

Table Major Buyers of Hemophilia Treatment Drugs

Table Distributors/Traders List

Figure Germany Hemophilia Treatment Drugs Sales and Growth Rate Forecast (2017-2022)

Figure Germany Hemophilia Treatment Drugs Revenue and Growth Rate Forecast (2017-2022)

Figure France Hemophilia Treatment Drugs Sales and Growth Rate Forecast (2017-2022)

Figure France Hemophilia Treatment Drugs Revenue and Growth Rate Forecast (2017-2022)

Figure UK Hemophilia Treatment Drugs Sales and Growth Rate Forecast (2017-2022)

Figure UK Hemophilia Treatment Drugs Revenue and Growth Rate Forecast (2017-2022)

Figure Russia Hemophilia Treatment Drugs Sales and Growth Rate Forecast (2017-2022)

Figure Russia Hemophilia Treatment Drugs Revenue and Growth Rate Forecast (2017-2022)

Figure Italy Hemophilia Treatment Drugs Sales and Growth Rate Forecast (2017-2022)

Figure Italy Hemophilia Treatment Drugs Revenue and Growth Rate Forecast (2017-2022)

Figure Spain Hemophilia Treatment Drugs Sales and Growth Rate Forecast (2017-2022)

Figure Spain Hemophilia Treatment Drugs Revenue and Growth Rate Forecast (2017-2022)

Figure Benelux Hemophilia Treatment Drugs Sales and Growth Rate Forecast (2017-2022)

Figure Benelux Hemophilia Treatment Drugs Revenue and Growth Rate Forecast (2017-2022)

Table Europe Hemophilia Treatment Drugs Sales Forecast by Type (2017-2022)

Table Europe Hemophilia Treatment Drugs Sales Forecast by Application (2017-2022)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370